Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
YYForce Inc. has partnered with Novotel and Mercure Singapore on Stevens to deploy humanoid robots across 772 guestrooms, restaurants, and event spaces.
Sangamo Therapeutics has initiated an auction process for its ST-503 program, a clinical-stage treatment for chronic neuropathic pain, with completion expected in Q4 2026.
Cincinnati Children's Hospital Medical Center published a special article in Pediatric Research outlining 10 priority research areas in pediatric health.
Castle Biosciences presented data from three studies at the ACG 2026 Annual Scientific Meeting showing TissueCypher can detect elevated risk of progression in Barrett's Esophagus beyond standard pathology findings.